,

You Can’t Be a Little Bit Pregnant

Olga Goodman, MD

On treatment, waiting, and the limits of a glass of water.

I began my medical career as an obstetrician-gynecologist. One useful truth survived my move into rheumatology: you can’t be a little bit pregnant.

Patients still try. Just in a different specialty.

“Doctor, let’s treat it just a little.”
“Something mild, please.”
“Let’s wait until summer.”

Inflammation, unfortunately, has no summer plans.

Picture a house on fire. The firefighters arrive, and you ask whether they could start with a glass of water. A hose sounds rather aggressive.

The house will not appreciate your restraint.

A woman offers a tiny glass of water to a firefighter beside a miniature house with stylized flames.
“Something milder” still has to do the job.

“Milder” can sound reassuring, but it is not a treatment goal. The goal is remission or low disease activity. Once active inflammatory disease is established, a plan that feels cautious still has to protect the patient.

A destination—and an alarm clock

When rheumatologists talk about an active approach, we mean starting in time, agreeing on a target, and checking whether we are getting there. Doctors call this “treat to target.” Think GPS: it can recalculate the route, but it should not pretend you have arrived.

There is an opposite problem, too. Someone takes a slow-acting medicine for three days, still has pain, and declares the experiment over. Some parcels take longer to arrive.

Medicines that modify the disease may need weeks or months. They deserve an adequate trial, with planned checks and a decision about what happens next. That is patience with an alarm clock.

Feeling better also deserves interpretation. It may mean the treatment is working. Reducing treatment can sometimes be appropriate in sustained remission—but with your doctor and a plan.

The limits of the joke

A positive ANA is not automatically lupus. Aching joints are not automatically arthritis. Sometimes monitoring is the right decision, and I will be the first to recommend it.

But monitoring has a subject, a timetable, and a threshold for action. We know what we are watching, when we will check again, and what would change the plan.

Without those, “monitoring” is a very impressive name for hoping.

Behind “just a little” there is usually fear. That deserves a serious conversation. A useful opening is: “What I’m most afraid of is…” Then another question belongs beside it: “What are we risking while I wait?”

I explore these questions, with illustrations and practical reading links, in the full essay.

Discuss treatment decisions with your treating physician; this essay is educational.

← More Insights

Olga Goodman, MD

Rheumatologist and creator of RheumaView™.